User menu

Economic impact of antidepressant treatment duration in naturalistic conditions

Bibliographic reference Tournier, Marie ; Crott, Ralph ; Gaudron, Yoan ; Verdoux, Hélène. Economic impact of antidepressant treatment duration in naturalistic conditions. In: Acta Psychiatrica Scandinavica, Vol. 127, no.5, p. 365-372 (2013)
Permanent URL http://hdl.handle.net/2078.1/142642
  1. Holma I. A. K., Holma K. M., Melartin T. K., Rytsälä H. J., Isometsä E. T., A 5-year prospective study of predictors for disability pension among patients with major depressive disorder : Disability pension and major depressive disorder, 10.1111/j.1600-0447.2011.01785.x
  2. Mathers Colin D, Loncar Dejan, Projections of Global Mortality and Burden of Disease from 2002 to 2030, 10.1371/journal.pmed.0030442
  3. Murray Christopher JL, Lopez Alan D, Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study, 10.1016/s0140-6736(96)07492-2
  4. Ustun T. B., Global burden of depressive disorders in the year 2000, 10.1192/bjp.184.5.386
  5. Wagner S., Doering B., Helmreich I., Lieb K., Tadić A., A meta-analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment : Executive dysfunctions in unipolar MDD, 10.1111/j.1600-0447.2011.01762.x
  6. Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, Matthews K, McAllister-Williams RH, Peveler RC, Scott J, Tylee A, Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines, 10.1177/0269881107088441
  7. Reid S., Barbui C., Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants, 10.1136/bmj.c1468
  8. Tournier M., Cougnard A., Boutouaba-Combe S., Verdoux H., Étude sur la durée des traitements antidépresseurs en France et ses déterminants à partir des bases de données de l’Assurance maladie, 10.1016/j.encep.2010.06.007
  9. Sanglier Thibaut, Saragoussi Delphine, Milea Dominique, Auray Jean-Paul, Valuck Robert J., Tournier Marie, Comparing Antidepressant Treatment Patterns in Older and Younger Adults: A Claims Database Analysis : ANTIDEPRESSANT TREATMENT IN OLDER AND YOUNGER ADULTS, 10.1111/j.1532-5415.2011.03457.x
  10. Tournier Marie, Moride Yola, Crott Ralph, Galbaud du Fort Guillaume, Ducruet Thierry, Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population, 10.1016/j.jad.2008.07.004
  11. Moride Yola, Du Fort Guillaume Galbaud, Monette Johanne, Ducruet Thierry, Boivin Jean-François, Nathalie Champoux MD, Crott Ralph, Suboptimal Duration of Antidepressant Treatments in the Older Ambulatory Population of Quebec: Association with Selected Physician Characteristics, 10.1046/j.1532-5415.2002.50357.x
  12. Verdoux H., Cougnard A., Thiébaut A., Tournier M., Impact of Duration of Antidepressant Treatment on the Risk of Occurrence of a New Sequence of Antidepressant Treatment, 10.1055/s-0031-1271686
  13. Gardarsdottir H., Egberts T. C., Stolker J. J., Heerdink E. R., Duration of Antidepressant Drug Treatment and Its Influence on Risk of Relapse/Recurrence: Immortal and Neglected Time Bias, 10.1093/aje/kwp142
  14. Gardarsdottir Helga, van Geffen Erica C.G., Stolker Joost J., Egberts Toine C.G., Heerdink Eibert R., Does the Length of the First Antidepressant Treatment Episode Influence Risk and Time to a Second Episode? : , 10.1097/jcp.0b013e31819302b1
  15. Aikens James E., Kroenke Kurt, Swindle Ralph W., Eckert George J., Nine-month predictors and outcomes of SSRI antidepressant continuation in primary care, 10.1016/j.genhosppsych.2005.04.001
  16. Mitchell Alex J, Vaze Amol, Rao Sanjay, Clinical diagnosis of depression in primary care: a meta-analysis, 10.1016/s0140-6736(09)60879-5
  17. Sewitch, Can J Psychiatry, 52, 191 (2007)
  18. Blais R, Partlová H, Lachaine J, Sewitch MJ, La conformité aux guides de traitement de la dépression est-elle associée à une réduction des coûts des services de santé ?, 10.3917/pos.414.0349
  19. Revicki, J Fam Pract, 47, 446 (1998)
  20. Cully J. A., Zimmer M., Khan M. M., Petersen L. A., Quality of Depression Care and Its Impact on Health Service Use and Mortality Among Veterans, 10.1176/appi.ps.59.12.1399
  21. Martin-Latry Karin, Bégaud Bernard, Pharmacoepidemiological research using French reimbursement databases: yes we can!, 10.1002/pds.1912
  22. WHO Collaborating Centre for Drug Statistics Methodology, About the ATC/DDD system (2007)
  23. STATA CORP, Stata Statistical Software: Release 11 (2009)
  24. Gibson, Am J Manag Care, 16, 370 (2010)
  25. Cantrell Christopher Ron, Eaddy Michael T., Shah Manan B., Regan Timothy S., Sokol Michael C., Methods for Evaluating Patient Adherence to Antidepressant Therapy : A Real-World Comparison of Adherence and Economic Outcomes, 10.1097/01.mlr.0000204287.82701.9b
  26. Bosmans J. E., de Bruijne M. C., de Boer M. R., van Hout H., van Steenwijk P., van Tulder M. W., Health care costs of depression in primary care patients in The Netherlands, 10.1093/fampra/cmq033
  27. Katon, J Clin Psychiatry, 59, 15 (1998)
  28. Barsky Arthur J., Somatized Psychiatric Disorder Presenting as Palpitations, 10.1001/archinte.1996.00040041102009
  29. Somatization and the recognition of depression and anxiety in primary care, 10.1176/ajp.150.5.734
  30. Barsky Arthur J., Orav E. John, Bates David W., Somatization Increases Medical Utilization and Costs Independent of Psychiatric and Medical Comorbidity, 10.1001/archpsyc.62.8.903
  31. Grolleau A., Cougnard A., Bégaud B., Verdoux H., Usage et congruence diagnostique des traitements à visée psychotrope : résultats de l’enquête santé mentale en population générale en France métropolitaine, 10.1016/j.encep.2007.07.011
  32. Grolleau, Acta Psychiatr Scand, 117, 20 (2008)